APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Targeting Peptides

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tumor Targeting Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchTumor Targeting Peptides Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Targeting Peptides Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Tumor Targeting Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Targeting Peptides Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Targeting Peptides Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Tumor Targeting Peptides market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tumor Targeting Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tumor Targeting Peptides include Advanced ChemTech, ASIA BIOSCIENCE CO, Bachem, Biorbyt, Cell Guidance Systems, CPC Scientific Inc, Danaher(Abcam), Merck KGaA and PEPTIDE INSTITUTE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tumor Targeting Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Targeting Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Targeting Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tumor Targeting Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Targeting Peptides Segment by Company

Advanced ChemTech

ASIA BIOSCIENCE CO

Bachem

Biorbyt

Cell Guidance Systems

CPC Scientific Inc

Danaher(Abcam)

Merck KGaA

PEPTIDE INSTITUTE

RayBiotech

Selleck Chemicals

TargetMol Chemicals

Cayman Chemical

QYAOBIO

Tumor Targeting Peptides Segment by Type

Therapeutic Targeting Peptides

Imaging Targeting Peptides

Tumor Targeting Peptides Segment by Application

Scientific Research

Pharmaceuticals

Tumor Targeting Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Targeting Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Targeting Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Targeting Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tumor Targeting Peptides market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tumor Targeting Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tumor Targeting Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tumor Targeting Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tumor Targeting Peptides Industry Trends Table 2. Tumor Targeting Peptides Industry Drivers Table 3. Tumor Targeting Peptides Industry Opportunities and Challenges Table 4. Tumor Targeting Peptides Industry Restraints Table 5. Global Tumor Targeting Peptides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tumor Targeting Peptides Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tumor Targeting Peptides Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Tumor Targeting Peptides Sales Market Share by Manufacturers Table 9. Global Tumor Targeting Peptides Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Tumor Targeting Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tumor Targeting Peptides Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tumor Targeting Peptides Manufacturers, Product Type & Application Table 13. Global Tumor Targeting Peptides Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tumor Targeting Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Therapeutic Targeting Peptides Table 17. Major Manufacturers of Imaging Targeting Peptides Table 18. Global Tumor Targeting Peptides Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Tumor Targeting Peptides Sales by Type (2021-2026) & (Kg) Table 20. Global Tumor Targeting Peptides Sales by Type (2027-2032) & (Kg) Table 21. Global Tumor Targeting Peptides Sales Market Share by Type (2021-2026) Table 22. Global Tumor Targeting Peptides Sales Market Share by Type (2027-2032) Table 23. Global Tumor Targeting Peptides Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Tumor Targeting Peptides Revenue by Type (2021-2026) & (Kg) Table 25. Global Tumor Targeting Peptides Revenue by Type (2027-2032) & (Kg) Table 26. Global Tumor Targeting Peptides Revenue Market Share by Type (2021-2026) Table 27. Global Tumor Targeting Peptides Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Scientific Research Table 29. Major Manufacturers of Pharmaceuticals Table 30. Global Tumor Targeting Peptides Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 31. Global Tumor Targeting Peptides Sales by Application (2021-2026) & (Kg) Table 32. Global Tumor Targeting Peptides Sales by Application (2027-2032) & (Kg) Table 33. Global Tumor Targeting Peptides Sales Market Share by Application (2021-2026) Table 34. Global Tumor Targeting Peptides Sales Market Share by Application (2027-2032) Table 35. Global Tumor Targeting Peptides Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Tumor Targeting Peptides Revenue by Application (2021-2026) & (Kg) Table 37. Global Tumor Targeting Peptides Revenue by Application (2027-2032) & (Kg) Table 38. Global Tumor Targeting Peptides Revenue Market Share by Application (2021-2026) Table 39. Global Tumor Targeting Peptides Revenue Market Share by Application (2027-2032) Table 40. Global Tumor Targeting Peptides Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 41. Global Tumor Targeting Peptides Sales by Region (2021-2026) & (Kg) Table 42. Global Tumor Targeting Peptides Sales Market Share by Region (2021-2026) Table 43. Global Tumor Targeting Peptides Sales Forecasted by Region (2027-2032) & (Kg) Table 44. Global Tumor Targeting Peptides Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 46. North America Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg) Table 47. North America Tumor Targeting Peptides Sales by Country (2027-2032) & (Kg) Table 48. Europe Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 49. Europe Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg) Table 50. Europe Tumor Targeting Peptides Sales by Country (2027-2032) & (Kg) Table 51. Asia Pacific Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 52. Asia Pacific Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg) Table 53. Asia Pacific Tumor Targeting Peptides Sales by Country (2027-2032) & (Kg) Table 54. South America, Middle East and Africa Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. South America, Middle East and Africa Tumor Targeting Peptides Sales by Country (2021-2026) & (Kg) Table 56. South America, Middle East and Africa Tumor Targeting Peptides Sales by Country (2027-2032) & (Kg) Table 57. Global Tumor Targeting Peptides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Tumor Targeting Peptides Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Tumor Targeting Peptides Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Tumor Targeting Peptides Revenue Market Share by Region (2021-2026) Table 61. Global Tumor Targeting Peptides Revenue Market Share by Region (2027-2032) Table 62. Advanced ChemTech Company Information Table 63. Advanced ChemTech Business Overview Table 64. Advanced ChemTech Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Advanced ChemTech Tumor Targeting Peptides Product Portfolio Table 66. Advanced ChemTech Recent Development Table 67. ASIA BIOSCIENCE CO Company Information Table 68. ASIA BIOSCIENCE CO Business Overview Table 69. ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. ASIA BIOSCIENCE CO Tumor Targeting Peptides Product Portfolio Table 71. ASIA BIOSCIENCE CO Recent Development Table 72. Bachem Company Information Table 73. Bachem Business Overview Table 74. Bachem Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bachem Tumor Targeting Peptides Product Portfolio Table 76. Bachem Recent Development Table 77. Biorbyt Company Information Table 78. Biorbyt Business Overview Table 79. Biorbyt Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Biorbyt Tumor Targeting Peptides Product Portfolio Table 81. Biorbyt Recent Development Table 82. Cell Guidance Systems Company Information Table 83. Cell Guidance Systems Business Overview Table 84. Cell Guidance Systems Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Cell Guidance Systems Tumor Targeting Peptides Product Portfolio Table 86. Cell Guidance Systems Recent Development Table 87. CPC Scientific Inc Company Information Table 88. CPC Scientific Inc Business Overview Table 89. CPC Scientific Inc Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. CPC Scientific Inc Tumor Targeting Peptides Product Portfolio Table 91. CPC Scientific Inc Recent Development Table 92. Danaher(Abcam) Company Information Table 93. Danaher(Abcam) Business Overview Table 94. Danaher(Abcam) Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Danaher(Abcam) Tumor Targeting Peptides Product Portfolio Table 96. Danaher(Abcam) Recent Development Table 97. Merck KGaA Company Information Table 98. Merck KGaA Business Overview Table 99. Merck KGaA Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Merck KGaA Tumor Targeting Peptides Product Portfolio Table 101. Merck KGaA Recent Development Table 102. PEPTIDE INSTITUTE Company Information Table 103. PEPTIDE INSTITUTE Business Overview Table 104. PEPTIDE INSTITUTE Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. PEPTIDE INSTITUTE Tumor Targeting Peptides Product Portfolio Table 106. PEPTIDE INSTITUTE Recent Development Table 107. RayBiotech Company Information Table 108. RayBiotech Business Overview Table 109. RayBiotech Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. RayBiotech Tumor Targeting Peptides Product Portfolio Table 111. RayBiotech Recent Development Table 112. Selleck Chemicals Company Information Table 113. Selleck Chemicals Business Overview Table 114. Selleck Chemicals Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Selleck Chemicals Tumor Targeting Peptides Product Portfolio Table 116. Selleck Chemicals Recent Development Table 117. TargetMol Chemicals Company Information Table 118. TargetMol Chemicals Business Overview Table 119. TargetMol Chemicals Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. TargetMol Chemicals Tumor Targeting Peptides Product Portfolio Table 121. TargetMol Chemicals Recent Development Table 122. Cayman Chemical Company Information Table 123. Cayman Chemical Business Overview Table 124. Cayman Chemical Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Cayman Chemical Tumor Targeting Peptides Product Portfolio Table 126. Cayman Chemical Recent Development Table 127. QYAOBIO Company Information Table 128. QYAOBIO Business Overview Table 129. QYAOBIO Tumor Targeting Peptides Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. QYAOBIO Tumor Targeting Peptides Product Portfolio Table 131. QYAOBIO Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Tumor Targeting Peptides Distributors List Table 135. Tumor Targeting Peptides Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Tumor Targeting Peptides Product Image Figure 2. Global Tumor Targeting Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Targeting Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor Targeting Peptides Sales (2021-2032) & (Kg) Figure 5. Global Tumor Targeting Peptides Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Tumor Targeting Peptides Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Therapeutic Targeting Peptides Image Figure 9. Imaging Targeting Peptides Image Figure 10. Global Tumor Targeting Peptides Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Tumor Targeting Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tumor Targeting Peptides Sales Market Share by Type (2021-2032) Figure 13. Global Tumor Targeting Peptides Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Tumor Targeting Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tumor Targeting Peptides Revenue Market Share by Type (2021-2032) Figure 16. Scientific Research Image Figure 17. Pharmaceuticals Image Figure 18. Global Tumor Targeting Peptides Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 19. Global Tumor Targeting Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Tumor Targeting Peptides Sales Market Share by Application (2021-2032) Figure 21. Global Tumor Targeting Peptides Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Tumor Targeting Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Tumor Targeting Peptides Revenue Market Share by Application (2021-2032) Figure 24. North America Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 25. North America Tumor Targeting Peptides Sales Market Share by Country (2021-2032) Figure 26. U.S. Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 27. Canada Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Mexico Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Europe Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Tumor Targeting Peptides Sales Market Share by Country (2021-2032) Figure 31. Germany Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 32. France Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 33. U.K. Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Italy Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Netherlands Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Asia Pacific Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Tumor Targeting Peptides Sales Market Share by Country (2021-2032) Figure 38. China Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Japan Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 40. South Korea Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Southeast Asia Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 42. India Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Australia Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South America, Middle East and Africa Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Tumor Targeting Peptides Sales Market Share by Country (2021-2032) Figure 46. Brazil Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South Africa Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 48. Saudi Arabia Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Turkey Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Argentina Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 51. UAE Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Egypt Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Chile Tumor Targeting Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Global Tumor Targeting Peptides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Tumor Targeting Peptides Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Tumor Targeting Peptides Revenue (2021-2032) & (US$ Million) Figure 57. North America Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Tumor Targeting Peptides Revenue (2021-2032) & (US$ Million) Figure 59. Europe Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Tumor Targeting Peptides Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Tumor Targeting Peptides Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Tumor Targeting Peptides Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Tumor Targeting Peptides Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Targeting Peptides
  • Imaging Targeting Peptides
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Advanced ChemTech
  • ASIA BIOSCIENCE CO
  • Bachem
  • Biorbyt
  • Cell Guidance Systems
  • CPC Scientific Inc
  • Danaher(Abcam)
  • Merck KGaA
  • PEPTIDE INSTITUTE
  • RayBiotech
  • Selleck Chemicals
  • TargetMol Chemicals
  • Cayman Chemical
  • QYAOBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tumor Targeting Peptides Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tumor Targeting Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tumor Targeting Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tumor Targeting Peptides Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tumor Targeting Peptides Market Dynamics
  1. 2.1 Tumor Targeting Peptides Industry Trends
  2. 2.2 Tumor Targeting Peptides Industry Drivers
  3. 2.3 Tumor Targeting Peptides Industry Opportunities and Challenges
  4. 2.4 Tumor Targeting Peptides Industry Restraints
3 Tumor Targeting Peptides Market by Manufacturers
  1. 3.1 Global Tumor Targeting Peptides Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tumor Targeting Peptides Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tumor Targeting Peptides Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tumor Targeting Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tumor Targeting Peptides Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tumor Targeting Peptides Manufacturers, Product Type & Application
  7. 3.7 Global Tumor Targeting Peptides Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tumor Targeting Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tumor Targeting Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tumor Targeting Peptides Tier 1, Tier 2, and Tier 3
4 Tumor Targeting Peptides Market by Type
  1. 4.1 Tumor Targeting Peptides Type Introduction
  2. 4.1.1 Therapeutic Targeting Peptides
  3. 4.1.2 Imaging Targeting Peptides
  4. 4.2 Global Tumor Targeting Peptides Sales by Type
  5. 4.2.1 Global Tumor Targeting Peptides Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tumor Targeting Peptides Sales by Type (2021-2032)
  7. 4.2.3 Global Tumor Targeting Peptides Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tumor Targeting Peptides Revenue by Type
  9. 4.3.1 Global Tumor Targeting Peptides Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tumor Targeting Peptides Revenue by Type (2021-2032)
  11. 4.3.3 Global Tumor Targeting Peptides Revenue Market Share by Type (2021-2032)
5 Tumor Targeting Peptides Market by Application
  1. 5.1 Tumor Targeting Peptides Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Pharmaceuticals
  4. 5.2 Global Tumor Targeting Peptides Sales by Application
  5. 5.2.1 Global Tumor Targeting Peptides Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tumor Targeting Peptides Sales by Application (2021-2032)
  7. 5.2.3 Global Tumor Targeting Peptides Sales Market Share by Application (2021-2032)
  8. 5.3 Global Tumor Targeting Peptides Revenue by Application
  9. 5.3.1 Global Tumor Targeting Peptides Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Tumor Targeting Peptides Revenue by Application (2021-2032)
  11. 5.3.3 Global Tumor Targeting Peptides Revenue Market Share by Application (2021-2032)
6 Global Tumor Targeting Peptides Sales by Region
  1. 6.1 Global Tumor Targeting Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor Targeting Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Tumor Targeting Peptides Sales by Region (2021-2026)
  4. 6.2.2 Global Tumor Targeting Peptides Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tumor Targeting Peptides Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tumor Targeting Peptides Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tumor Targeting Peptides Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tumor Targeting Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tumor Targeting Peptides Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tumor Targeting Peptides Revenue by Region
  1. 7.1 Global Tumor Targeting Peptides Revenue by Region
  2. 7.1.1 Global Tumor Targeting Peptides Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tumor Targeting Peptides Revenue by Region (2021-2026)
  4. 7.1.3 Global Tumor Targeting Peptides Revenue by Region (2027-2032)
  5. 7.1.4 Global Tumor Targeting Peptides Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tumor Targeting Peptides Revenue (2021-2032)
  8. 7.2.2 North America Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tumor Targeting Peptides Revenue (2021-2032)
  11. 7.3.2 Europe Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tumor Targeting Peptides Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tumor Targeting Peptides Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tumor Targeting Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Advanced ChemTech
  2. 8.1.1 Advanced ChemTech Company Information
  3. 8.1.2 Advanced ChemTech Business Overview
  4. 8.1.3 Advanced ChemTech Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Advanced ChemTech Tumor Targeting Peptides Product Portfolio
  6. 8.1.5 Advanced ChemTech Recent Developments
  7. 8.2 ASIA BIOSCIENCE CO
  8. 8.2.1 ASIA BIOSCIENCE CO Company Information
  9. 8.2.2 ASIA BIOSCIENCE CO Business Overview
  10. 8.2.3 ASIA BIOSCIENCE CO Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ASIA BIOSCIENCE CO Tumor Targeting Peptides Product Portfolio
  12. 8.2.5 ASIA BIOSCIENCE CO Recent Developments
  13. 8.3 Bachem
  14. 8.3.1 Bachem Company Information
  15. 8.3.2 Bachem Business Overview
  16. 8.3.3 Bachem Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bachem Tumor Targeting Peptides Product Portfolio
  18. 8.3.5 Bachem Recent Developments
  19. 8.4 Biorbyt
  20. 8.4.1 Biorbyt Company Information
  21. 8.4.2 Biorbyt Business Overview
  22. 8.4.3 Biorbyt Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biorbyt Tumor Targeting Peptides Product Portfolio
  24. 8.4.5 Biorbyt Recent Developments
  25. 8.5 Cell Guidance Systems
  26. 8.5.1 Cell Guidance Systems Company Information
  27. 8.5.2 Cell Guidance Systems Business Overview
  28. 8.5.3 Cell Guidance Systems Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cell Guidance Systems Tumor Targeting Peptides Product Portfolio
  30. 8.5.5 Cell Guidance Systems Recent Developments
  31. 8.6 CPC Scientific Inc
  32. 8.6.1 CPC Scientific Inc Company Information
  33. 8.6.2 CPC Scientific Inc Business Overview
  34. 8.6.3 CPC Scientific Inc Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CPC Scientific Inc Tumor Targeting Peptides Product Portfolio
  36. 8.6.5 CPC Scientific Inc Recent Developments
  37. 8.7 Danaher(Abcam)
  38. 8.7.1 Danaher(Abcam) Company Information
  39. 8.7.2 Danaher(Abcam) Business Overview
  40. 8.7.3 Danaher(Abcam) Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Danaher(Abcam) Tumor Targeting Peptides Product Portfolio
  42. 8.7.5 Danaher(Abcam) Recent Developments
  43. 8.8 Merck KGaA
  44. 8.8.1 Merck KGaA Company Information
  45. 8.8.2 Merck KGaA Business Overview
  46. 8.8.3 Merck KGaA Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck KGaA Tumor Targeting Peptides Product Portfolio
  48. 8.8.5 Merck KGaA Recent Developments
  49. 8.9 PEPTIDE INSTITUTE
  50. 8.9.1 PEPTIDE INSTITUTE Company Information
  51. 8.9.2 PEPTIDE INSTITUTE Business Overview
  52. 8.9.3 PEPTIDE INSTITUTE Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PEPTIDE INSTITUTE Tumor Targeting Peptides Product Portfolio
  54. 8.9.5 PEPTIDE INSTITUTE Recent Developments
  55. 8.10 RayBiotech
  56. 8.10.1 RayBiotech Company Information
  57. 8.10.2 RayBiotech Business Overview
  58. 8.10.3 RayBiotech Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 RayBiotech Tumor Targeting Peptides Product Portfolio
  60. 8.10.5 RayBiotech Recent Developments
  61. 8.11 Selleck Chemicals
  62. 8.11.1 Selleck Chemicals Company Information
  63. 8.11.2 Selleck Chemicals Business Overview
  64. 8.11.3 Selleck Chemicals Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Selleck Chemicals Tumor Targeting Peptides Product Portfolio
  66. 8.11.5 Selleck Chemicals Recent Developments
  67. 8.12 TargetMol Chemicals
  68. 8.12.1 TargetMol Chemicals Company Information
  69. 8.12.2 TargetMol Chemicals Business Overview
  70. 8.12.3 TargetMol Chemicals Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 TargetMol Chemicals Tumor Targeting Peptides Product Portfolio
  72. 8.12.5 TargetMol Chemicals Recent Developments
  73. 8.13 Cayman Chemical
  74. 8.13.1 Cayman Chemical Company Information
  75. 8.13.2 Cayman Chemical Business Overview
  76. 8.13.3 Cayman Chemical Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cayman Chemical Tumor Targeting Peptides Product Portfolio
  78. 8.13.5 Cayman Chemical Recent Developments
  79. 8.14 QYAOBIO
  80. 8.14.1 QYAOBIO Company Information
  81. 8.14.2 QYAOBIO Business Overview
  82. 8.14.3 QYAOBIO Tumor Targeting Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 QYAOBIO Tumor Targeting Peptides Product Portfolio
  84. 8.14.5 QYAOBIO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tumor Targeting Peptides Value Chain Analysis
  2. 9.1.1 Tumor Targeting Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tumor Targeting Peptides Production Mode & Process
  6. 9.2 Tumor Targeting Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tumor Targeting Peptides Distributors
  9. 9.2.3 Tumor Targeting Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst